Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 DOVU DOVU +50.13%
#3 Black Phoenix Black Phoenix +35.20%
#4 Velvet Velvet +24.01%
#5 Akedo Akedo +19.78%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#7 Fake World Assets Fake World Assets +17.01%
#8 DoubleZero DoubleZero +12.65%
#9 clBTC clBTC +11.84%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.21%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Rangering i aksjer #39914
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Aksjekurs
$0.00366968
Sist synkronisert: 2024-07-12
Markedsverdi
$299.46K
Endring (1 dag)
-66.77%
Endring (1 år)
0.00%
Land
CA
Handel Biocure Technology Inc. (CURE)

Kategori

Healthcare
Antall utestående aksjer for Biocure Technology Inc. (CURE)
Antall utestående aksjer per August 2026: 0
Ifølge Biocure Technology Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Biocure Technology Inc. (CURE) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE